United States · 
Who invested in Entrade Therapeutics?
Entrade Therapeutics's investors include 5AM Ventures, MRL Fund, Agent and MPM Capital/ Roche.
United States · Series A startup
Who invested in Entrade Therapeutics
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Entrade Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 27 Oct 2026
$59Mraised across 1 round since 2018, from 1 source
- Latest round
- Series A, $59MDec 2018
- Investors
- 4
The rounds
- Dec 2018
Everyone who backed them
Agentno record of our own yet1round
MPM Capital/ Rocheno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Entrade Therapeutics
How much has Entrade Therapeutics raised?
Entrade Therapeutics has raised $59M across 1 round since 2018.
When did Entrade Therapeutics last raise?
Entrade Therapeutics's most recent round was a Series A of $59M in Dec 2018.
What was Entrade Therapeutics's biggest round?
Its most recent round, $59M in Dec 2018, is also its largest on record.
Who backed Entrade Therapeutics first?
Entrade Therapeutics's first round on record, in Dec 2018, was backed by 5AM Ventures, MRL Fund and Agent and 1 others.
What stage is Entrade Therapeutics at?
Entrade Therapeutics's latest named round is a Series A, in Dec 2018.
Where is Entrade Therapeutics based?
Entrade Therapeutics is based in the United States.
Companies like Entrade Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.